Back Safe switching of warfarin to DOACs

This needs to be undertaken in a phased manner over the 12-week cycle of INR monitoring to protect the supply chain for ALL patients. As highlighted, many patients are not suitable for a switch from warfarin to DOACs and further guidance will be available shortly to support services providing care for these patients. Further information here.